Trans Health HQ Selected for the Harvard HealthLab Accelerator

AllCompany Announcements
Written By Ivan Hsiao

Harvard HealthLab Accelerators (H2A) selected Trans Health HQ for their 2024 Harvard Cohort. Read the H2A press release here.

Ivan Hsiao
Previous

Harvard Innovation Labs Selects Trans Health HQ as a Finalist in the President’s Innovation Challenge